Biologist Sunaina Pai examines breast cancer cells at Forma Therapeutics in Cambridge.
(Globe Staff Photo / Matthew J. Lee)
Forma Therapeutics bucks trend, raises $25m from investors
Biologist Sunaina Pai examines breast cancer cells at Forma Therapeutics in Cambridge.
(Globe Staff Photo / Matthew J. Lee)
Forma Therapeutics Inc., a stealth biotech start-up trying to develop cancer drugs, is lifting its corporate veil. (Full article: 291 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
